Actions

Reports: FDA to consider boosters for the immunocompromised

Multiple reports say the FDA is planning to review CDC data in the next week or so.

Scripps file photo

Around 3,000 Arizonans are participating in a COVID-19 study run out of the University of Arizona.

By: Newsy Staff

Posted

and last updated

The FDA could approve vaccine booster shots for some of the most vulnerable Americans within weeks.

According to multiple reports, in the next week or so, the FDA is planning to review CDC data on additional doses for the immunocompromised.

That includes people who have gotten organ transplants, are being treated for cancer, or have HIV, just to name a few.

Newsy 2021